Cabot Co. (NYSE:CBT) Stock Holdings Lifted by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC lifted its position in Cabot Co. (NYSE:CBT) by 21.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,031 shares of the specialty chemicals company’s stock after acquiring an additional 1,593 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Cabot were worth $825,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CBT. American Century Companies Inc. increased its stake in Cabot by 8.5% in the 4th quarter. American Century Companies Inc. now owns 1,323,347 shares of the specialty chemicals company’s stock valued at $120,835,000 after buying an additional 103,380 shares during the period. Sei Investments Co. increased its stake in Cabot by 6.0% in the 4th quarter. Sei Investments Co. now owns 942,273 shares of the specialty chemicals company’s stock valued at $86,039,000 after buying an additional 53,090 shares during the period. Invesco Ltd. increased its stake in Cabot by 7.1% in the 4th quarter. Invesco Ltd. now owns 845,261 shares of the specialty chemicals company’s stock valued at $77,181,000 after buying an additional 55,905 shares during the period. Northern Trust Corp increased its stake in Cabot by 12.4% in the 4th quarter. Northern Trust Corp now owns 794,477 shares of the specialty chemicals company’s stock valued at $72,544,000 after buying an additional 87,881 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in Cabot by 0.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 710,608 shares of the specialty chemicals company’s stock valued at $64,886,000 after buying an additional 3,175 shares during the period. 93.18% of the stock is owned by hedge funds and other institutional investors.

Cabot Price Performance

NYSE CBT opened at $76.70 on Tuesday. The company has a quick ratio of 1.29, a current ratio of 2.00 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $4.12 billion, a PE ratio of 10.19, a price-to-earnings-growth ratio of 0.74 and a beta of 0.87. The company has a 50 day moving average price of $76.59 and a two-hundred day moving average price of $85.80. Cabot Co. has a 12-month low of $71.64 and a 12-month high of $117.46.

Cabot (NYSE:CBT) last posted its earnings results on Monday, May 5th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.86 by $0.04. The firm had revenue of $936.00 million during the quarter, compared to analysts’ expectations of $1.02 billion. Cabot had a net margin of 10.60% and a return on equity of 26.79%. The company’s revenue was down 8.1% compared to the same quarter last year. During the same period in the previous year, the company earned $1.78 earnings per share. As a group, equities analysts predict that Cabot Co. will post 7.57 earnings per share for the current fiscal year.

Cabot Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 30th will be paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.35%. This is a boost from Cabot’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Friday, May 30th. Cabot’s payout ratio is presently 23.29%.

Analysts Set New Price Targets

CBT has been the topic of several research reports. Wall Street Zen lowered shares of Cabot from a “buy” rating to a “hold” rating in a research note on Wednesday, May 7th. JPMorgan Chase & Co. dropped their price objective on shares of Cabot from $105.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, February 21st. Finally, UBS Group dropped their price objective on shares of Cabot from $93.00 to $83.00 and set a “neutral” rating on the stock in a research note on Monday, April 7th.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.